Literature DB >> 17126812

Ablation of the mammalian methionine sulfoxide reductase A affects the expression level of cysteine deoxygenase.

Derek B Oien1, Jackob Moskovitz.   

Abstract

Methionine sulfoxide reductases (Msrs) are able to reduce methionine sulfoxide to methionine both in proteins and free amino acids. By their action it is possible to regulate the function of specific proteins and the cellular antioxidant defense against oxidative damage. Similarly, cysteine deoxygenase (CDO) may be involved in the regulation of protein function and antioxidant defense mechanisms by its ability to oxidized cysteine residues. The two enzymes' involvement in sulfur amino-acids metabolism seems to be connected. Lack of methionine sulfoxide reductase A (MsrA) in liver of MsrA-/- led to a significant drop in the cellular level of thiol groups and lowered the CDO level of expression. Moreover, following selenium deficient diet (applied to decrease the expression levels of selenoproteins like MsrB), the latter effect was maintained while the basal levels of thiol decreased in both mouse strains. We suggest that both enzymes are working in coordination to balance cellular antioxidant defense.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126812     DOI: 10.1016/j.bbrc.2006.11.063

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients.

Authors:  Dimo Dietrich; Manuel Krispin; Jörn Dietrich; Anne Fassbender; Jörn Lewin; Nadia Harbeck; Manfred Schmitt; Serenella Eppenberger-Castori; Vincent Vuaroqueaux; Frédérique Spyratos; John A Foekens; Ralf Lesche; John W M Martens
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

2.  Mammals reduce methionine-S-sulfoxide with MsrA and are unable to reduce methionine-R-sulfoxide, and this function can be restored with a yeast reductase.

Authors:  Byung Cheon Lee; Dung Tien Le; Vadim N Gladyshev
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

3.  Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.

Authors:  Mariana Brait; Shizhang Ling; Jatin K Nagpal; Xiaofei Chang; Hannah Lui Park; Juna Lee; Jun Okamura; Keishi Yamashita; David Sidransky; Myoung Sook Kim
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

4.  Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.

Authors:  Naoko Minatani; Mina Waraya; Keishi Yamashita; Mariko Kikuchi; Hideki Ushiku; Ken Kojo; Akira Ema; Hiroshi Nishimiya; Yoshimasa Kosaka; Hiroshi Katoh; Norihiko Sengoku; Hirokazu Tanino; David Sidransky; Masahiko Watanabe
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

5.  Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma.

Authors:  Jung-Il Choi; Eung-Ho Cho; Sang Bum Kim; Ryounggo Kim; Junhye Kwon; Misun Park; Hye-Jin Shin; Han Suk Ryu; Sun-Hoo Park; Kee-Ho Lee
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2017-11-30

6.  Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's Contracture.

Authors:  Latha Satish; William A LaFramboise; David B O'Gorman; Sandra Johnson; Benjamin Janto; Bing Siang Gan; Mark E Baratz; Fen Z Hu; J Christopher Post; Garth D Ehrlich; Sandeep Kathju
Journal:  BMC Med Genomics       Date:  2008-04-23       Impact factor: 3.063

7.  Analysis of the methylation of CpG islands in the CDO1, TAC1 and CHFR genes in pancreatic ductal cancer.

Authors:  Hiroshi Maekawa; Tomoaki Ito; Hajime Orita; Tomoyuki Kushida; Mutsumi Sakurada; Koichi Sato; Alicia Hulbert; Malcolm V Brock
Journal:  Oncol Lett       Date:  2020-01-23       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.